Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473794 · ClinicalTrials.gov registry record
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
A clinical trial of Pancreas Cancer and Pancreatic Neoplasms, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT04473794 is a study of Pancreas Cancer and Pancreatic Neoplasms that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 5,000 participants, above the 815-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (513% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04473794, a study of Pancreas Cancer and Pancreatic Neoplasms, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.
Conditions Studied
Study Locations (1)
Maryland
- The Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2036-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04473794
The ClinicalTrials.gov registry entry for NCT04473794 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 815-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (513% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pancreas Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT04473794 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04473794 about?
NCT04473794 is a clinical study titled "Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts". The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, ...
What is the current status of trial NCT04473794?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2022-07-20. Estimated completion is 2036-08-01.
What conditions does trial NCT04473794 study?
This clinical trial studies the following conditions: Pancreas Cancer, Pancreatic Neoplasms.
Who is sponsoring clinical trial NCT04473794?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04473794 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreas Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
RECRUITING · Phase 2
-
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RECRUITING
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
The Cancer of the Pancreas Screening-5 CAPS5)Study
RECRUITING · Phase 3
-
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.